ExodusPoint Capital Management’s scPharmaceuticals SCPH Stock Holding History

ExodusPoint Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31,528	Closed	-$179K	–	2007
2025 Q3	$179K	Buy	+31,528	New	+$161K	﹤0.01%	1400
2020 Q3	–	Sell	-10,013	Closed	-$74K	–	2178
2020 Q2	$74K	Buy	+10,013	New	+$88K	﹤0.01%	1660

ExodusPoint Capital Management's SCPH Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 31,528 shares — an estimated $179K sold.

ExodusPoint Capital Management first reported a position in SCPH in Q2 2020 and held it in 2 quarters. The position peaked at $179K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

ExodusPoint Capital Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 31,528 scPharmaceuticals shares in Q4 2025, an estimated $179K.
ExodusPoint Capital Management first reported a position in scPharmaceuticals in Q2 2020 and held it in 2 quarters.
ExodusPoint Capital Management's scPharmaceuticals position peaked at $179K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.